Deanna P Jannat-Khah

15PUBLICATIONS
44CO-AUTHORS
DermatologyAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Clinical chemistry (incl. diagnostics)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 01, 2026
Treating skin involvement in diffuse cutaneous systemic sclerosis: results from an international scleroderma specialist survey.

|May 28, 2026
Comparing immune-checkpoint inhibitor-mediated inflammatory arthritis to polymyalgia rheumatica: a prospective cohort study.

|Nov 25, 2025
Are Glucocorticoids Associated With Worse Survival Among Patients With Rheumatoid Arthritis and Lung Cancer Treated With Immune Checkpoint Inhibitors?

Deanna Jannat-Khah, Jeffrey R Curtis, Fenglong Xie

|Sep 01, 2025
Skin Biopsies Enhance Prediction of Clinical Trajectory in Diffuse Cutaneous Systemic Sclerosis.

Kimberly S Lakin, John Spivack, Jessica K Gordon

|Jul 07, 2025
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions.

Medha Barbhaiya, Stephane Zuily, Deanna Jannat-Khah

|Apr 28, 2025
Survival in Immune Checkpoint Inhibitor-Treated Patients With Rheumatoid Arthritis and Non-Small Cell Lung Cancer: An Observational Cohort Study.

Deanna P Jannat-Khah, Fenglong Xie, Ashish Saxena

Pageof 3

Frequent Collaborators

3 joint publications

Anne R Bass

3 joint publications

Robert Spiera

2 joint publications

Pankti Reid

2 joint publications

Medha Barbhaiya